Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations

Chun-Nin Lee, Hsiang Yin Chen, H. Eugene Liu

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations'. Together they form a unique fingerprint.